When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BCLI - FDA accepts Brainstorm's NurOwn IND application for progressive multiple sclerosis
Brainstorm Cell Therapeutics Inc.
The FDA has accepted BrainStorm Cell Therapeutics' (NASDAQ:BCLI) IND application to initiate a Phase 2 clinical trial of NurOwn for the treatment of progressive multiple sclerosis (MS).
More news on: BrainStorm Cell Therapeutics Inc., Healthcare stocks news, Stocks on the move,